- Home
- CRNX vs FICO Comparison
CRNX vs FICO Comparison
Compare CRNX & FICO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- FICO
- Stock Information
- Founded
- CRNX 2008
- FICO 1956
- Country
- CRNX United States
- FICO United States
- Employees
- CRNX N/A
- FICO N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- FICO Business Services
- Sector
- CRNX Health Care
- FICO Consumer Discretionary
- Exchange
- CRNX Nasdaq
- FICO Nasdaq
- Market Cap
- CRNX 2.8B
- FICO 32.2B
- IPO Year
- CRNX 2018
- FICO 1987
- Fundamental
- Price
- CRNX $33.77
- FICO $1,555.42
- Analyst Decision
- CRNX Strong Buy
- FICO Buy
- Analyst Count
- CRNX 7
- FICO 12
- Target Price
- CRNX $74.33
- FICO $2,068.67
- AVG Volume (30 Days)
- CRNX 1.1M
- FICO 317.7K
- Earning Date
- CRNX 11-11-2025
- FICO 11-05-2025
- Dividend Yield
- CRNX N/A
- FICO N/A
- EPS Growth
- CRNX N/A
- FICO 34.32
- EPS
- CRNX N/A
- FICO 25.55
- Revenue
- CRNX $1,392,000.00
- FICO $1,928,927,000.00
- Revenue This Year
- CRNX $489.51
- FICO $18.02
- Revenue Next Year
- CRNX $661.93
- FICO $13.91
- P/E Ratio
- CRNX N/A
- FICO $60.88
- Revenue Growth
- CRNX 0.51
- FICO 16.66
- 52 Week Low
- CRNX $24.10
- FICO $1,300.00
- 52 Week High
- CRNX $62.53
- FICO $2,402.52
- Technical
- Relative Strength Index (RSI)
- CRNX 56.44
- FICO 59.49
- Support Level
- CRNX $33.19
- FICO $1,511.04
- Resistance Level
- CRNX $37.23
- FICO $1,598.00
- Average True Range (ATR)
- CRNX 1.45
- FICO 41.36
- MACD
- CRNX 0.11
- FICO 14.12
- Stochastic Oscillator
- CRNX 52.12
- FICO 78.96
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About FICO Fair Isaac Corproation
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.